Goldman Sachs Equity Income C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Goldman Sachs Equity Income Fund Class C GSGCX
- NAV / 1-Day Return 48.65 / +0.54 %
- Total Assets 446.9M
-
Adj. Expense Ratio
1.740%
- Expense Ratio 1.740%
- Distribution Fee Level Average
- Share Class Type Level Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.51%
- Turnover 35%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 12:10 AM GMT+0
Morningstar’s Analysis GSGCX
Will GSGCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the GSGCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of GSGCX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Exxon Mobil Corp | 4.42 | 19M | Energy |
JPMorgan Chase & Co | 4.05 | 17M | Financial Services |
Johnson & Johnson | 3.85 | 16M | Healthcare |
Walmart Inc | 2.61 | 11M | Consumer Defensive |
Alphabet Inc Class A | 2.55 | 11M | Communication Services |
Caterpillar Inc | 2.53 | 11M | Industrials |
Bank of America Corp | 2.28 | 10M | Financial Services |
Linde PLC | 2.27 | 10M | Basic Materials |
Procter & Gamble Co | 2.10 | 9M | Consumer Defensive |
Merck & Co Inc | 2.10 | 9M | Healthcare |
United States